The Journal of Steroid Biochemistry and Molecular Biology

Editorial board
pp. CO2-CO2(1)

Homology modelling of the nuclear receptors: human oestrogen receptor (hER), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor (hER) crystal structure, and the human peroxisome proliferator activated receptor (PPAR) ligand binding domain from the human PPAR crystal structure
pp. 117-132(16)
Authors: Jacobs M.N.; Dickins M.; Lewis D.F.V.

Expression of estrogen receptor exon-deleted variant mRNAs in ovary and uterine endometrium
pp. 133-140(8)
Authors: Fujimoto J.; Sun W.-S.; Misao R.; Sakaguchi H.; Aoki I.; Toyoki H.; Tamaya T.

Kinetic analysis of estrogen receptor homo- and heterodimerization in vitro
pp. 141-148(8)
Authors: Jisa E.; Jungbauer A.

Phytoestrogen regulation of a Vitamin D₃ receptor promoter and 1,25-dihydroxyvitamin D₃ actions in human breast cancer cells
pp. 149-157(9)
Authors: Wietzke J.A.; Welsh J.

The gastrointestinal tract as target of steroid hormone action: Quantification of steroid receptor mRNA expression (AR, ER, ER and PR) in 10 bovine gastrointestinal tract compartments by kinetic RT-PCR
pp. 159-166(8)
Authors: Pfaffl M.W.; Lange I.G.; Meyer H.H.D.

Functional interaction of estrogen receptor and caveolin isoforms in neuronal SK-N-MC cells
pp. 167-170(4)
Authors: Zschocke J.; Manthey D.; Bayatti N.; Behl C.

Overexpressed glucocorticoid receptor negatively regulates gene expression under conditions that favour accumulation of non-hormone-binding forms of the receptor
pp. 171-180(10)
Authors: Siriani D.; Mitsiou D.J.; Alexis M.N.

Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion
pp. 181-192(12)
Authors: Flanagan L.; Packman K.; Juba B.; O'Neill S.; Tenniswood M.; Welsh J.

Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines - Effect on sulfatase activity in comparison to medroxyprogesterone acetate
pp. 193-198(6)
Authors: Pasqualini J.R.; Caubel P.; Friedman A.J.; Philippe J.-C.; Chetrite G.S.

Induction of apoptosis by 1,25-dihydroxyvitamin D₃ in MCF-7 Vitamin D₃-resistant variant can be sensitized by TPA
pp. 199-209(11)
Authors: Narvaez C.J.; Byrne B.M.; Romu S.; Valrance M.; Welsh J.

Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study
pp. 211-216(6)
Authors: Pena L.; Silvan G.; Perez-Alenza M.D.; Nieto A.; Illera J.C.

Effects of various steroids on platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA expression in uterine endometrial cancer cells
pp. 217-222(6)
Authors: Aoki I.; Fujimoto J.; Tamaya T.

Identification of a Vitamin D response element in the human insulin receptor gene promoter
pp. 223-230(8)
Authors: Maestro B.; Davila N.; Carranza M.C.; Calle C.

Characterisation of gene expression patterns in 22RV1 cells for determination of environmental androgenic/antiandrogenic compounds
pp. 231-238(8)
Authors: Hartel A.; Didier A.; Pfaffl M.W.; Meyer H.H.D.

Glucocorticoid metabolism by 11- hydroxysteroid dehydrogenase type 2 modulates human mineralocorticoid receptor transactivation activity
pp. 239-244(6)
Authors: Bocchi B.; Fagart J.; Cluzeaud F.; Fay M.; Rafestin-Oblin M.-E.; Farman N.

Solubilization and photoaffinity labeling identification of glucocorticoid binding peptides in endoplasmic reticulum from rat liver
pp. 245-253(9)
Authors: Perez-Machn R.; Henrquez-Hernandez L.; Perez-Luzardo O.; Betancor-Hernandez E.; Tabares-Domnguez E.; Mateos-Daz C.; Novoa-Mogollon J.; Daz-Chico B.N.; Fernandez L.

Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation
pp. 255-257(3)
Authors: Seeger H.; Diesing D.; Guckel B.; Wallwiener D.; Mueck A.O.; Huober J.

Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy
pp. 259-268(10)
Authors: Beck V.; Unterrieder E.; Krenn L.; Kubelka W.; Jungbauer A.

Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate
pp. 269-278(10)
Authors: Suzuki R.N.; Newman S.P.; Purohit A.; Leese M.P.; Potter B.V.L.; Reed M.J.

Expression and localization of estrogen receptor , estrogen receptor and progesterone receptor in the bovine oviduct in vivo and in vitro
pp. 279-289(11)
Authors: Ulbrich S.E.; Kettler A.; Einspanier R.

Steroidogenesis during in vitro maturation of bovine cumulus oocyte complexes and possible effects of tri-butyltin on granulosa cells
pp. 291-300(10)
Authors: Schoenfelder M.; Schams D.; Einspanier R.

Estrogen-induced cell signalling in a cellular model of Alzheimer's disease
pp. 301-305(5)
Authors: Goodenough S.; Schafer M.; Behl C.

The content of four immunomodulatory steroids and major androgens in human semen
pp. 307-316(10)
Authors: Hampl R.; Pohanka M.; Hill M.; Starka L.

The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells
pp. 317-325(9)
Authors: Day J.M.; Newman S.P.; Comninos A.; Solomon C.; Purohit A.; Leese M.P.; Potter B.V.L.; Reed M.J.

In vitro and in vivo models for the evaluation of new inhibitors of human steroid sulfatase, devoid of residual estrogenic activity
pp. 327-335(9)
Authors: Shields-Botella J.; Bonnet P.; Duc I.; Duranti E.; Meschi S.; Cardinali S.; Prouheze P.; Chaigneau A.M.; Duranti V.; Gribaudo S.; Riviere A.; Mengual L.; Carniato D.; Cecchet L.; Lafay J.; Rondot B.; Sandri J.; Pascal J.C.; Delansorne R.

Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo
pp. 337-342(6)
Authors: Ireson C.R.; Parish D.; Purohit A.; Woo L.W.L.; Potter B.V.L.; Chander S.K.; Reed M.J.

Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity
pp. 343-349(7)
Authors: Fischer D.S.; Chander S.K.; Woo L.W.L.; Fenton J.C.; Purohit A.; Reed M.J.; Potter B.V.L.

Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate
pp. 351-358(8)
Authors: Raobaikady B.; Purohit A.; Chander S.K.; Woo L.W.L.; Leese M.P.; Potter B.V.L.; Reed M.J.

8-Prenyl naringenin is a potent ER selective phytoestrogen present in hops and beer
pp. 359-360(2)
Authors: Schaefer O.; Humpel M.; Fritzemeier K.-H.; Bohlmann R.; Schleuning W.-D.

Tamoxifen administration and metabolism in nude mice and nude rats
pp. 361-367(7)
Authors: Kisanga E.R.; Gjerde J.; Schjott J.; Mellgren G.; Lien E.A.

Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers
pp. 369-375(7)
Authors: Urhausen A.; Torsten A.; Wilfried K.

Amplified androstenedione enzymeimmunoassay for the diagnosis of cryptorchidism in the male horse: comparison with testosterone and estrone sulphate methods
pp. 377-382(6)
Authors: Illera J.C.; Silvan G.; Munro C.J.; Lorenzo P.L.; Illera M.J.; Liu I.K.M.; Illera M.

Headspace solid-phase microextraction (SPME) and gas chromatography-mass spectrometry (GC-MS) for the determination of 5-androst-2-en-17-one and -17-ol in the female Asian elephant: application for reproductive monitoring and prediction of parturition
pp. 383-391(9)
Authors: Dehnhard M.; Hatt J.-M.; Eulenberger K.; Ochs A.; Strauss G.